世界最新医学信息文摘(连续型电子期刊)
世界最新醫學信息文摘(連續型電子期刊)
세계최신의학신식문적(련속형전자기간)
World Latest Medicine Information
2015年
38期
7,9
,共2页
铝碳酸镁%奥美拉唑%十二指肠球部溃疡
鋁碳痠鎂%奧美拉唑%十二指腸毬部潰瘍
려탄산미%오미랍서%십이지장구부궤양
Hydrotalcite%Omeprazole%duodenal ulcer
目的 了解分析十二指肠球部溃疡患者应用铝碳酸镁联合奥美拉唑方案治疗的临床价值.方法 纳入本院近年来收治十二指肠球部溃疡患者为本次研究对象,随机抽取80例并根据治疗方案差异将其分为对照组与观察组,对照组患者40例,方案为奥美拉唑治疗,观察组患者40例,在对照组治疗基础上联合铝碳酸镁.对比2组患者临床疗效与安全性.结果 完成疗程后评估对比2组患者临床疗效,观察组患者总有效率92.5%,与对照组总有效率82.5%相对比两者存在统计学价值(P<0.05);2组患者治疗期间均无发生药物不良反应.结论 对十二指肠球部溃疡患者采取铝碳酸镁联合奥美拉唑方案进行治疗不但临床疗效令人满意,且不会提高患者治疗过程中药物相关不良反应发生率,具备安全高效的优点,值得临床普及推广.
目的 瞭解分析十二指腸毬部潰瘍患者應用鋁碳痠鎂聯閤奧美拉唑方案治療的臨床價值.方法 納入本院近年來收治十二指腸毬部潰瘍患者為本次研究對象,隨機抽取80例併根據治療方案差異將其分為對照組與觀察組,對照組患者40例,方案為奧美拉唑治療,觀察組患者40例,在對照組治療基礎上聯閤鋁碳痠鎂.對比2組患者臨床療效與安全性.結果 完成療程後評估對比2組患者臨床療效,觀察組患者總有效率92.5%,與對照組總有效率82.5%相對比兩者存在統計學價值(P<0.05);2組患者治療期間均無髮生藥物不良反應.結論 對十二指腸毬部潰瘍患者採取鋁碳痠鎂聯閤奧美拉唑方案進行治療不但臨床療效令人滿意,且不會提高患者治療過程中藥物相關不良反應髮生率,具備安全高效的優點,值得臨床普及推廣.
목적 료해분석십이지장구부궤양환자응용려탄산미연합오미랍서방안치료적림상개치.방법 납입본원근년래수치십이지장구부궤양환자위본차연구대상,수궤추취80례병근거치료방안차이장기분위대조조여관찰조,대조조환자40례,방안위오미랍서치료,관찰조환자40례,재대조조치료기출상연합려탄산미.대비2조환자림상료효여안전성.결과 완성료정후평고대비2조환자림상료효,관찰조환자총유효솔92.5%,여대조조총유효솔82.5%상대비량자존재통계학개치(P<0.05);2조환자치료기간균무발생약물불량반응.결론 대십이지장구부궤양환자채취려탄산미연합오미랍서방안진행치료불단림상료효령인만의,차불회제고환자치료과정중약물상관불량반응발생솔,구비안전고효적우점,치득림상보급추엄.
Objective: To evaluate the clinical value of the treatment of duodenal ulcer patients combined with omeprazole for hydrotalcite.Methods:In our hospital in recent years were duodenal ulcer patients as the research object, randomly select-ed 80 patients according to treatment differences will be divided into control group and observation group, 40 patients in control group patients, for omeprazole treatment, 40 patients in the observation group, on the basis of control group treatment combined with hydrotalcite. Comparison of 2 groups of patients with clinical efficacy and safety.Results: 2 groups of patients with clinical curative effect comparison of the evaluation after completion of treatment, the total efficiency of the observation group and the control group 92.5%, the total efficiency of 82.5% compared to two significant values (P<0.05); during the 2 groups of patients had no adverse drug reaction.Conclusion:The treatment of hydrotalcite plus omeprazole not only satisfactory clinical effects on patients with duodenal ulcer, and will not increase the incidence of adverse drug reactions of patients during the treatment, has the advantages of safe and effective, worthy of clinical popularization.